StonvexLoading…
StonvexStonvexStonvexCore line items from FCEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $30.53M | $158.16M | $103.15M | $56.40M |
Operating Income | $-26.29M | $-192.35M | $-164.03M | $-68.66M |
Net Income | $-22.86M | $-187.90M | $-158.03M | $-66.38M |
EPS (Diluted) | $-0.49 | $-7.42 | $-7.22 | $-3.22 |
Total Assets | $978.48M | $932.15M | $830.53M | $883.84M |
Total Liabilities | $214.48M | $201.00M | $205.46M | $205.05M |
Cash & Equivalents | $311.78M | $278.10M | $174.66M | $116.06M |
Free Cash Flow OCF − CapEx | $-34.71M | $-143.89M | $-120.01M | $-87.94M |
Shares Outstanding | 52.61M | 46.08M | 29.65M | 22.78M |